Loading stock data…
$98.29-0.48 (-0.49%)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States.
Kimberly-Clark Corporation in the Consumer Defensive sector is trading at $98.29 with a market capitalization of $34.9B. Wall Street consensus targets $114.80 (15 analysts), implying a +16.8% move over the next 12 months. The stock is currently near its 52-week low of $92.42, remaining 2.1% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $4.19B↑ | $4.16B↑ | $4.08B↓ | $4.15B↓ | $4.16B |
| Gross Profit | $1.60B↑ | $1.53B↑ | $1.47B↓ | $1.49B↑ | $1.46B |
| Operating Income | $633.00M↓ | $753.00M↑ | $507.00M↓ | $621.00M↑ | $592.00M |
| Net Income | $345.00M↓ | $665.00M↑ | $499.00M↑ | $446.00M↓ | $509.00M |
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates in two segments, North America and International Personal Care. The North America segment offers disposable ...
Academic risk and quality models computed from KMB's own filings and price history, not from analyst opinion.
Mixed: 4 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 21.9% reading.
Fama-French 5-factor market beta. The five factors explain 17% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-13.